{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:26:13Z","timestamp":1793841973105,"version":"4.6.1"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jcmgh.2026.101920","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:24:50Z","timestamp":1792106690000},"page":"101920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Host Restriction Factors in Hepatitis B Virus\u2013Related Liver Disease and Hepatocellular Carcinoma: Mechanisms of Viral\u2013Host Interplay and Implications for Therapy"],"prefix":"10.1016","author":[{"given":"Zepei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H.","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8026-9311","authenticated-orcid":false,"given":"Carsten","family":"M\u00fcnk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2026.101920_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/vaccines12030288","article-title":"Global perspectives on the hepatitis B vaccination: challenges, achievements, and the road to elimination by 2030","volume":"12","author":"Al-Busafi","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jcmgh.2026.101920_bib2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jcmgh.2026.101920_bib3","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1128\/jvi.69.6.3350-3357.1995","article-title":"The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes","volume":"69","author":"Newbold","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib4","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1136\/gutjnl-2014-308943","article-title":"Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure","volume":"64","author":"Zeisel","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101920_bib5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/v16050764","article-title":"Intracellular host restriction of hepatitis B virus replication","volume":"16","author":"Sinha","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.jcmgh.2026.101920_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coi.2015.06.016","article-title":"Host-virus interactions in hepatitis B virus infection","volume":"36","author":"Guidotti","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib7","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2026.101920_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.28013","article-title":"A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses","volume":"63","author":"Verrier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101920_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/gutjnl-2018-317065","article-title":"Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets","volume":"69","author":"Verrier","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101920_bib10","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1038\/s41467-020-16517-w","article-title":"A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor","volume":"11","author":"Eller","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101920_bib11","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.3390\/ijms21155203","article-title":"The roles of immune cells in the pathogenesis of fibrosis","volume":"21","author":"Huang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2026.101920_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib13","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","author":"Maini","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcmgh.2026.101920_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4110\/in.2015.15.4.191","article-title":"Immune-mediated liver injury in hepatitis B virus infection","volume":"15","author":"Oh","year":"2015","journal-title":"Immune Netw"},{"key":"10.1016\/j.jcmgh.2026.101920_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","article-title":"A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells","volume":"135","author":"Hoechst","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101920_bib16","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1016\/j.cell.2024.05.038","article-title":"Therapeutic potential of co-signaling receptor modulation in hepatitis B","volume":"187","author":"Andreata","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101920_bib17","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41590-024-01928-4","article-title":"Attenuated effector T cells are linked to control of chronic HBV infection","volume":"25","author":"Heim","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41586-024-07630-7","article-title":"A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection","volume":"631","author":"Bosch","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101920_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004032","article-title":"Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages","volume":"10","author":"Bility","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2026.101920_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib21","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.3748\/wjg.v20.i30.10238","article-title":"Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma","volume":"20","author":"Ali","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib22","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/gutjnl-2018-316510","article-title":"Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma","volume":"68","author":"Lim","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101920_bib23","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/gutjnl-2017-314098","article-title":"Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101920_bib24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbamcr.2018.09.012","article-title":"From APOBEC to ZAP: diverse mechanisms used by cellular restriction factors to inhibit virus infections","volume":"1866","author":"Chemudupati","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.jcmgh.2026.101920_bib26","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3390\/v12060592","article-title":"Hepatitis B virus DNA is a substrate for the cGAS\/STING Pathway but is not Sensed in Infected Hepatocytes","volume":"12","author":"Lauterbach-Rivi\u00e8re","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jcmgh.2026.101920_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2024.102413","article-title":"Structure-function of type I and III interferons","volume":"86","author":"de Weerd","year":"2024","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib28","article-title":"Type I interferons in bacterial diseases: myeloid cells at the crossroads of protection and pathology","volume":"16","author":"Lyadova","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.antiviral.2009.10.011","article-title":"Inhibition of STAT1 methylation is involved in the resistance of hepatitis B virus to interferon alpha","volume":"85","author":"Li","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcmgh.2026.101920_bib30","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.cell.2017.06.042","article-title":"Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity","volume":"170","author":"Chen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101920_bib31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fimmu.2015.00334","article-title":"MicroRNA as Type I interferon-regulated transcripts and modulators of the innate immune response","volume":"6","author":"Forster","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhep.2022.02.016","article-title":"Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection","volume":"77","author":"Montanari","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib33","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.2147\/IDR.S484265","article-title":"The mechanism of APOBEC3B in hepatitis B virus infection and HBV related hepatocellular carcinoma progression, therapeutic and prognostic potential","volume":"17","author":"Yang","year":"2024","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jcmgh.2026.101920_bib34","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/jvh.12689","article-title":"Hepatitis B virus covalently closed circular DNA homeostasis is independent of the lymphotoxin pathway during chronic HBV infection","volume":"24","author":"Meier","year":"2017","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jcmgh.2026.101920_bib35","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2026.101920_bib36","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"3","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.jcmgh.2026.101920_bib37","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101920_bib38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/v14040727","article-title":"IFITM3 Interacts with the HBV\/HDV receptor NTCP and modulates virus entry and infection","volume":"14","author":"Palatini","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jcmgh.2026.101920_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa2213429","article-title":"A phase 3, randomized trial of bulevirtide in chronic hepatitis D","volume":"389","author":"Wedemeyer","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmgh.2026.101920_bib40","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41467-021-21821-0","article-title":"Circadian control of hepatitis B virus replication","volume":"12","author":"Zhuang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101920_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013581","article-title":"HBV p22-interacting protein C1QBP inhibits viral replication through impeding nucleocapsid formation and nuclear import","volume":"21","author":"Peng","year":"2025","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2026.101920_bib42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jcmgh.2022.05.007","article-title":"HIRA supports hepatitis B virus minichromosome establishment and transcriptional activity in infected hepatocytes","volume":"14","author":"Locatelli","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib43","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.cell.2025.01.033","article-title":"A nucleosome switch primes hepatitis B virus infection","volume":"188","author":"Prescott","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101920_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011180","article-title":"The SMC5\/6 complex: an emerging antiviral restriction factor that can silence episomal DNA","volume":"19","author":"Irwan","year":"2023","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2026.101920_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/v16111667","article-title":"SMC5\/6-mediated transcriptional regulation of hepatitis B virus and its therapeutic potential","volume":"16","author":"Bacher","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.jcmgh.2026.101920_bib46","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/s41594-022-00829-0","article-title":"Smc5\/6 silences episomal transcription by a three-step function","volume":"29","author":"Abdul","year":"2022","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib47","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsiere","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101920_bib48","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","article-title":"Hepatitis B virus X protein promotes degradation of SMC5\/6 to enhance HBV replication","volume":"16","author":"Murphy","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcmgh.2026.101920_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02415-24","article-title":"Augmented epigenetic repression of hepatitis B virus covalently closed circular DNA by interferon-\u03b1 and small-interfering RNA synergy","volume":"15","author":"Hu","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.jcmgh.2026.101920_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00677-22","article-title":"Dual-role of cholesterol-25-hydroxylase in regulating hepatitis B virus infection and replication","volume":"13","author":"Wei","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.jcmgh.2026.101920_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01198-25","article-title":"Interferon-induced miR-7705 modulates the anti-virus activity of cholesterol 25-hydroxylase","volume":"99","author":"Wang","year":"2025","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib52","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jhep.2021.06.038","article-title":"Novel function of SART1 in HNF4\u03b1 transcriptional regulation contributes to its antiviral role during HBV infection","volume":"75","author":"Teng","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib53","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jhep.2025.11.017","article-title":"A genome-wide siRNA screen identifies previously unknown proviral and antiviral host factors in HBV infection","volume":"84","author":"Cheng","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib54","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.virs.2025.02.004","article-title":"Sphingomyelin phosphodiesterase 3 as a novel host factor inhibiting hepatitis B virus transcription","volume":"40","author":"Li","year":"2025","journal-title":"Virol Sin"},{"key":"10.1016\/j.jcmgh.2026.101920_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01235-22","article-title":"Hepatitis B virus X protein inhibits the expression of barrier to autointegration factor1 via upregulating miR-203 expression in hepatic cells","volume":"11","author":"Mishra","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jcmgh.2026.101920_bib56","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1093\/nar\/gkab110","article-title":"Barrier-to-autointegration-factor (Banf1) modulates DNA double-strand break repair pathway choice via regulation of DNA-dependent kinase (DNA-PK) activity","volume":"49","author":"Burgess","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcmgh.2026.101920_bib57","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1093\/nar\/gkab184","article-title":"Di-phosphorylated BAF shows altered structural dynamics and binding to DNA, but interacts with its nuclear envelope partners","volume":"49","author":"Marcelot","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcmgh.2026.101920_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkag073","article-title":"Chromatin remodeler BAF maintains HBV cccDNA transcriptional competence and represents a therapeutic target","volume":"54","author":"Huang","year":"2026","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcmgh.2026.101920_bib59","article-title":"Identification and characterization of multiple TRIM proteins that inhibit hepatitis B virus transcription","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2026.101920_bib60","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hep.23011","article-title":"Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain","volume":"50","author":"Gao","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101920_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105406","article-title":"TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity","volume":"207","author":"Tian","year":"2022","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcmgh.2026.101920_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00468-24","article-title":"Tripartite motif-containing protein 21 is involved in IFN-\u03b3-induced suppression of hepatitis B virus by regulating hepatocyte nuclear factors","volume":"98","author":"Won","year":"2024","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.02309-24","article-title":"Ubiquitin-dependent proteasomal degradation of small hepatitis B virus surface antigen mediated by TRIM21 and antagonized by OTUD4","volume":"99","author":"Wu","year":"2025","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib64","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/apt.17124","article-title":"TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFN\u03b1 treatment response of HBeAg-positive chronic hepatitis B Patients","volume":"56","author":"Luo","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcmgh.2026.101920_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40688-3","article-title":"TRIM26 positively affects hepatitis B virus replication by inhibiting proteasome-dependent degradation of viral core protein","volume":"13","author":"Nakaya","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101920_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/v16060890","article-title":"Tripartite motif-containing protein 65 (TRIM65) inhibits hepatitis B virus transcription","volume":"16","author":"Shen","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.jcmgh.2026.101920_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186982","article-title":"PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core","volume":"12","author":"Lubyova","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2026.101920_bib68","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/hep.29133","article-title":"PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation","volume":"66","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101920_bib69","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase","volume":"63","author":"Rivi\u00e8re","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010576","article-title":"Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA","volume":"18","author":"Kim","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2026.101920_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01509-25","article-title":"Interferon alpha-inducible protein 27 (IFI27) inhibits hepatitis B virus (HBV) transcription through downregulating cellular transcription factor C\/EBP\u03b1","volume":"99","author":"Yu","year":"2025","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib72","doi-asserted-by":"crossref","first-page":"16003","DOI":"10.18632\/oncotarget.7435","article-title":"ZEB2 inhibits HBV transcription and replication by targeting its core promoter","volume":"7","author":"He","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcmgh.2026.101920_bib73","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00767-21","article-title":"MafF is an antiviral host factor that suppresses transcription from hepatitis b virus core promoter","volume":"95","author":"Ibrahim","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib74","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.3389\/fmicb.2018.03253","article-title":"B-Cell Lymphoma 6 (BCL6) is a host restriction factor that can suppress HBV gene expression and modulate immune responses","volume":"9","author":"Lin","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib75","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.antiviral.2018.03.008","article-title":"Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic manners","volume":"153","author":"Xu","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcmgh.2026.101920_bib76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2148-12-71","article-title":"An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammals","volume":"12","author":"M\u00fcnk","year":"2012","journal-title":"BMC Evol Biol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib77","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"Mangeat","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101920_bib78","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/hep.21733","article-title":"Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C","volume":"46","author":"Baumert","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101920_bib79","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2017.11.006","article-title":"APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription","volume":"149","author":"Chen","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcmgh.2026.101920_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100889","article-title":"APOBEC3-induced mutation of the hepatitis virus B DNA genome occurs during its viral RNA reverse transcription into (-)-DNA","volume":"297","author":"Chen","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcmgh.2026.101920_bib81","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.1073\/pnas.0408223102","article-title":"Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo","volume":"102","author":"Suspene","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2026.101920_bib82","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/jvh.12110","article-title":"Full genome ultra-deep pyrosequencing associates G-to-A hypermutation of the hepatitis B virus genome with the natural progression of hepatitis B","volume":"20","author":"Beggel","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jcmgh.2026.101920_bib83","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1126\/science.1092066","article-title":"Inhibition of hepatitis B virus replication by APOBEC3G","volume":"303","author":"Turelli","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2026.101920_bib84","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.3748\/wjg.v12.i28.4492","article-title":"Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo","volume":"12","author":"Lei","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib85","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1099\/vir.0.82319-0","article-title":"Dual effect of APOBEC3G on hepatitis B virus","volume":"88","author":"Noguchi","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib86","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/JVI.02510-06","article-title":"Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G","volume":"81","author":"Nguyen","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003361","article-title":"Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA","volume":"9","author":"Kitamura","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2026.101920_bib88","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949568","article-title":"Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20","volume":"22","author":"Stadler","year":"2021","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jcmgh.2026.101920_bib89","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jhep.2025.09.033","article-title":"HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responses","volume":"84","author":"Yuan","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib90","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkag149","article-title":"hnRNPA2B1 induces HBV cccDNA degradation by recruiting APOBEC3B","volume":"54","author":"Fu","year":"2026","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcmgh.2026.101920_bib91","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.21187","article-title":"Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication","volume":"43","author":"Bonvin","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101920_bib92","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-gamma and tumor necrosis factor-alpha produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101920_bib93","article-title":"Control of APOBEC3B induction and cccDNA decay by NF-kappaB and miR-138-5p","volume":"3","author":"Faure-Dupuy","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jcmgh.2026.101920_bib94","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/hep.31902","article-title":"Hypoxia-inducible factor 1 alpha-mediated RelB\/APOBEC3B down-regulation allows hepatitis B virus persistence","volume":"74","author":"Riedl","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101920_bib95","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.21893","article-title":"Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma","volume":"46","author":"Xu","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101920_bib96","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.omtn.2023.04.016","article-title":"Transient and tunable CRISPRa regulation of APOBEC\/AID genes for targeting hepatitis B virus","volume":"32","author":"Kostyushev","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jcmgh.2026.101920_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2024.103734","article-title":"Regulation, functional impact, and therapeutic targeting of APOBEC3A in cancer","volume":"141","author":"Kawale","year":"2024","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.jcmgh.2026.101920_bib98","doi-asserted-by":"crossref","first-page":"31715","DOI":"10.1074\/jbc.M113.501122","article-title":"Interleukin-1 and tumor necrosis factor-\u03b1 trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID)","volume":"288","author":"Watashi","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcmgh.2026.101920_bib99","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.antiviral.2017.01.004","article-title":"Activation of TNF-\u03b1-AID axis and co-inhibitory signals in coordination with Th1-type immunity in a mouse model recapitulating hepatitis B","volume":"139","author":"Matsumoto","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcmgh.2026.101920_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006296","article-title":"Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA","volume":"13","author":"Liu","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2026.101920_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008338","article-title":"Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified hepatitis B virus transcripts","volume":"16","author":"Imam","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2026.101920_bib102","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12985-015-0245-0","article-title":"The efficacy of zinc finger antiviral protein against hepatitis B virus transcription and replication in tansgenic mouse model","volume":"12","author":"Chen","year":"2015","journal-title":"Virol J"},{"key":"10.1016\/j.jcmgh.2026.101920_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003494","article-title":"Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein","volume":"9","author":"Mao","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2026.101920_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112460","article-title":"Cell-intrinsic regulation of HBV RNAs by the nonsense-mediated mRNA decay pathway controls viral replication","volume":"28","author":"Wada","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.jcmgh.2026.101920_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2026.116328","article-title":"A key role for the exoribonuclease XRN1 in regulating the hepatitis B viral transcriptome","volume":"29","author":"Tsukuda","year":"2026","journal-title":"iScience"},{"key":"10.1016\/j.jcmgh.2026.101920_bib106","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","article-title":"The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus","volume":"42","author":"Sato","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jcmgh.2026.101920_bib107","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00444-21","article-title":"RNA helicase DDX17 inhibits hepatitis B virus replication by blocking viral pregenomic RNA encapsidation","volume":"95","author":"Mao","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib108","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1128\/JVI.00011-09","article-title":"DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids","volume":"83","author":"Wang","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib109","doi-asserted-by":"crossref","first-page":"13689","DOI":"10.1128\/JVI.02035-14","article-title":"DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional level","volume":"88","author":"Ko","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib110","doi-asserted-by":"crossref","first-page":"19804","DOI":"10.1074\/jbc.RA119.009435","article-title":"The MOV10 helicase restricts hepatitis B virus replication by inhibiting viral reverse transcription","volume":"294","author":"Liu","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcmgh.2026.101920_bib111","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.bbrc.2014.07.023","article-title":"Inhibition of hepatitis B virus replication by SAMHD1","volume":"450","author":"Chen","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcmgh.2026.101920_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/srep26616","article-title":"Restrictive influence of SAMHD1 on hepatitis B virus life cycle","volume":"6","author":"Sommer","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101920_bib113","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virol.2016.05.001","article-title":"Inhibition of hepatitis B virus replication by a dNTPase-dependent function of the host restriction factor SAMHD1","volume":"495","author":"Jeong","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.jcmgh.2026.101920_bib114","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1128\/JVI.01998-10","article-title":"Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells","volume":"85","author":"Mao","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2009.08.039","article-title":"Tetherin inhibits HIV-1 release by directly tethering virions to cells","volume":"139","author":"Perez-Caballero","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101920_bib116","doi-asserted-by":"crossref","first-page":"9200","DOI":"10.1128\/JVI.00933-15","article-title":"The interferon-inducible protein tetherin inhibits hepatitis B virus virion secretion","volume":"89","author":"Yan","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/srep11736","article-title":"Identification of BST-2\/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation","volume":"5","author":"Lv","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101920_bib118","doi-asserted-by":"crossref","first-page":"21840","DOI":"10.18632\/oncotarget.4808","article-title":"Molecular dissection of HBV evasion from restriction factor tetherin: a new perspective for antiviral cell therapy","volume":"6","author":"Miyakawa","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcmgh.2026.101920_bib119","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fmicb.2020.00697","article-title":"SERINC5 Inhibits the secretion of complete and genome-free hepatitis B virions through interfering with the glycosylation of the HBV envelope","volume":"11","author":"Liu","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib120","first-page":"7762","article-title":"Correlation of APOBEC3 in tumor tissues with clinico-pathological features and survival from hepatocellular carcinoma after curative hepatectomy","volume":"8","author":"Yang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jcmgh.2026.101920_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157708","article-title":"Association of hepatitis B virus covalently closed circular DNA and human APOBEC3B in hepatitis B virus-related hepatocellular carcinoma","volume":"11","author":"Luo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2026.101920_bib122","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1111\/j.1742-4658.2012.08745.x","article-title":"Hepatitis B virus X protein and c-Myc cooperate in the upregulation of ribosome biogenesis and in cellular transformation","volume":"279","author":"Shukla","year":"2012","journal-title":"FEBS J"},{"key":"10.1016\/j.jcmgh.2026.101920_bib123","doi-asserted-by":"crossref","first-page":"120","DOI":"10.37349\/etat.2024.00209","article-title":"The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates","volume":"5","author":"Agustiningsih","year":"2024","journal-title":"Explor Target Antitumor Ther"},{"key":"10.1016\/j.jcmgh.2026.101920_bib124","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1080\/21655979.2021.1931640","article-title":"Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis","volume":"12","author":"Zhang","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.jcmgh.2026.101920_bib125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2021.08.010","article-title":"HBx-induced degradation of Smc5\/6 complex impairs homologous recombination-mediated repair of damaged DNA","volume":"76","author":"Sekiba","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib126","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbrc.2022.03.137","article-title":"Hepatitis B virus-associated hepatocellular carcinoma with Smc5\/6 complex deficiency is susceptible to PARP inhibitors","volume":"607","author":"Funato","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcmgh.2026.101920_bib127","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ajhg.2011.04.010","article-title":"Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome","volume":"88","author":"Puente","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jcmgh.2026.101920_bib128","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"83","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra2211764","article-title":"New approaches to chronic hepatitis B","volume":"388","author":"Dusheiko","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmgh.2026.101920_bib130","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1056\/NEJMoa2210027","article-title":"Efficacy and safety of bepirovirsen in chronic hepatitis B infection","volume":"387","author":"Yuen","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmgh.2026.101920_bib131","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa2515131","article-title":"Phase 3 results of bepirovirsen treatment for chronic hepatitis B virus infection","volume":"394","author":"Hou","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmgh.2026.101920_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106321","article-title":"Update on combination therapies against HBV in clinical investigations","volume":"245","author":"Mak","year":"2026","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcmgh.2026.101920_bib133","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jhep.2022.09.027","article-title":"Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression","volume":"78","author":"Gane","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib134","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1097\/HEP.0000000000001006","article-title":"A randomized phase 2b study of subcutaneous PD-L1 antibody ASC22 in virally suppressed patients with chronic hepatitis B who are HBeAg-negative","volume":"81","author":"Qian","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101920_bib135","first-page":"S1","article-title":"Brelovitug (BJT-778) monotherapy achieved 100% virologic response in patients with chronic hepatitis D: on treatment week 48 phase 2 study results","volume":"82","author":"Kosh Agarwal","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101920_bib136","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78001-1","article-title":"Quantification and epigenetic evaluation of the residual pool of hepatitis B covalently closed circular DNA in long-term nucleoside analogue-treated patients","volume":"10","author":"Lebosse","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101920_bib137","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140584","article-title":"Single hepatocytes show persistence and transcriptional inactivity of hepatitis B","volume":"5","author":"Balagopal","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcmgh.2026.101920_bib138","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/infdis\/jiz607","article-title":"Single hepatocyte hepatitis B virus transcriptional landscape in HIV coinfection","volume":"221","author":"Balagopal","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcmgh.2026.101920_bib139","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161818","article-title":"Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment","volume":"132","author":"Grudda","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcmgh.2026.101920_bib140","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/infdis\/jiad124","article-title":"Hepatitis B e antigen-negative single hepatocyte analysis shows transcriptional silencing and slow decay of infected cells with treatment","volume":"228","author":"Thio","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcmgh.2026.101920_bib141","article-title":"Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA","volume":"12","author":"Ren","year":"2025","journal-title":"Genes Dis"},{"key":"10.1016\/j.jcmgh.2026.101920_bib142","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.omtn.2020.03.005","article-title":"Permanent inactivation of HBV genomes by CRISPR\/Cas9-mediated non-cleavage base editing","volume":"20","author":"Yang","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jcmgh.2026.101920_bib143","article-title":"Disrupting viral persistence: CRISPR\/Cas9-based strategies for hepatitis B and C treatment, and challenges","volume":"30","author":"Li","year":"2026","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jcmgh.2026.101920_bib144","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11262-024-02105-3","article-title":"Tackling hepatitis B virus with CRISPR\/Cas9: advances, challenges, and delivery strategies","volume":"60","author":"Nair","year":"2024","journal-title":"Virus Genes"},{"key":"10.1016\/j.jcmgh.2026.101920_bib145","doi-asserted-by":"crossref","DOI":"10.1038\/srep13734","article-title":"CRISPR\/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X","volume":"5","author":"Karimova","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101920_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/v14010004","article-title":"Recent progress and future prospective in HBV cure by CRISPR\/Cas","volume":"14","author":"Yang","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jcmgh.2026.101920_bib147","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3390\/cells9040834","article-title":"Hepatitis B virus HBx protein mediates the degradation of host restriction factors through the cullin 4 DDB1 E3 ubiquitin ligase complex","volume":"9","author":"Minor","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jcmgh.2026.101920_bib148","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0241","article-title":"RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg","volume":"9","author":"Wooddell","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcmgh.2026.101920_bib149","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jhep.2024.03.046","article-title":"JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2","volume":"81","author":"Agarwal","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101920_bib150","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S2468-1253(23)00148-6","volume":"8","author":"Yuen","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:33:10Z","timestamp":1793838790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X26001980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":150,"alternative-id":["S2352345X26001980"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101920","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host Restriction Factors in Hepatitis B Virus\u2013Related Liver Disease and Hepatocellular Carcinoma: Mechanisms of Viral\u2013Host Interplay and Implications for Therapy","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101920"}}